InvestSMART

Echo IQ Limited (ASX:EIQ)

ALERT: Price-sensitive ASX Announcement for EIQ
Current share price for EIQ : $1.615 -0.005 (-0.31%)+
Announcement
Release
2 Jul 2026 8:51AM
Price at Release
$1.620
Full Release
download
Summary
Echo IQ Limited, a company specializing in AI-driven cardiology solutions, has announced a strategic partnership with Advara HeartCare to access a substantial dataset of de-identified echocardiography studies. This dataset, consisting of up to one million studies, will significantly bolster Echo IQ's AI development, training, and validation in cardiovascular diagnostics. By combining this new dataset with its existing National Echo Database Australia (NEDA) resources, Echo IQ aims to create a robust ecosystem for AI-enabled cardiovascular solutions. The agreement includes stringent data quality and confidentiality standards, and the initial delivery is subject to ethics approval.
Key Points
  • Echo IQ Limited has secured a strategic partnership with Advara HeartCare, providing exclusive access to a large echocardiography dataset.
  • The dataset includes 500,000 to 1,000,000 de-identified echocardiography studies with associated clinical data.
  • This partnership is expected to significantly enhance Echo IQ's AI development capabilities, particularly for cardiovascular diagnostics.
  • The Advara dataset complements Echo IQ's existing relationship with the National Echo Database Australia (NEDA).
  • The agreement supports the development of the EchoSolv platform and strengthens Echo IQ's competitive position in AI cardiovascular diagnostics.
  • The dataset will undergo an ethics approval process and must meet specific quality specifications before delivery.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.